Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
Prestige Consumer Healthcare (NYSE:PBH) has announced two important upcoming events. First, the company will release its fiscal 2025 third quarter earnings on Thursday, February 6, 2025, before market opening, followed by a conference call at 8:30 a.m. ET. Investors can join the webcast through the company's Investor Relations webpage or register for phone participation.
Additionally, PBH will participate in a fireside chat at the 27th annual ICR Conference in Orlando, FL on Tuesday, January 14th, at 11:30 a.m. ET. Both events will be accessible via webcast on the company's website, with replays available afterward.
Prestige Consumer Healthcare (NYSE:PBH) ha annunciato due importanti eventi in arrivo. Innanzitutto, l'azienda pubblicherà i suoi risultati del terzo trimestre fiscale 2025 giovedì 6 febbraio 2025, prima dell'apertura del mercato, seguito da una teleconferenza alle 8:30 del mattino, ora ET. Gli investitori possono partecipare al webcast tramite la pagina delle Relazioni con gli Investitori dell'azienda o registrarsi per la partecipazione telefonica.
Inoltre, PBH parteciperà a un fireside chat durante la 27ª Conferenza annuale ICR a Orlando, FL, martedì 14 gennaio, alle 11:30 del mattino, ora ET. Entrambi gli eventi saranno accessibili tramite webcast sul sito web dell'azienda, con le registrazioni disponibili successivamente.
Prestige Consumer Healthcare (NYSE:PBH) ha anunciado dos importantes eventos próximos. Primero, la empresa publicará sus resultados del tercer trimestre fiscal 2025 el jueves 6 de febrero de 2025, antes de la apertura del mercado, seguido de una llamada de conferencia a las 8:30 a.m. ET. Los inversores pueden unirse a la transmisión web a través de la página web de Relaciones con Inversores de la empresa o registrarse para participar por teléfono.
Además, PBH participará en un fireside chat en la 27ª Conferencia Anual ICR en Orlando, FL, el martes 14 de enero, a las 11:30 a.m. ET. Ambos eventos serán accesibles a través de la transmisión web en el sitio web de la empresa, con repeticiones disponibles posteriormente.
프레스티지 소비자 건강 (NYSE:PBH)가 두 가지 중요한 다가오는 이벤트를 발표했습니다. 첫째, 이 회사는 2025 회계연도 3분기 실적을 2025년 2월 6일 목요일, 시장 개장 전에 발표하며, 오전 8시 30분 ET에 컨퍼런스 콜이 이어질 예정입니다. 투자자들은 회사의 투자자 관계 웹페이지를 통해 웹캐스트에 참여하거나 전화 참여를 등록할 수 있습니다.
또한 PBH는 플로리다주 올랜도에서 열리는 제27회 연례 ICR 컨퍼런스에서 화요일, 1월 14일 오전 11시 30분 ET에 '파이어사이드 챗'에 참여할 예정입니다. 두 이벤트 모두 회사 웹사이트를 통해 웹캐스트로 접근할 수 있으며, 이후 다시보기도 가능합니다.
Prestige Consumer Healthcare (NYSE:PBH) a annoncé deux événements importants à venir. Tout d'abord, la société publiera ses résultats du troisième trimestre fiscal 2025 le jeudi 6 février 2025, avant l'ouverture du marché, suivi d'un appel conférence à 8h30, heure de l'Est. Les investisseurs peuvent rejoindre le webinaire via la page des Relations avec les Investisseurs de l'entreprise ou s'inscrire pour participer par téléphone.
De plus, PBH participera à un fireside chat lors de la 27ème conférence annuelle ICR à Orlando, FL, le mardi 14 janvier à 11h30, heure de l'Est. Les deux événements seront accessibles via webinaire sur le site de l'entreprise, avec des rediffusions disponibles par la suite.
Prestige Consumer Healthcare (NYSE:PBH) hat zwei wichtige bevorstehende Veranstaltungen angekündigt. Zunächst wird das Unternehmen am Donnerstag, den 6. Februar 2025, vor Markteröffnung seine Ergebnisse für das dritte Quartal des Geschäftsjahres 2025 veröffentlichen, gefolgt von einer Telefonkonferenz um 8:30 Uhr ET. Investoren können über die Investor Relations-Webseite des Unternehmens an dem Webcast teilnehmen oder sich für eine telefonische Teilnahme registrieren.
Darüber hinaus wird PBH an einem Fireside Chat auf der 27. jährlichen ICR-Konferenz in Orlando, FL, am Dienstag, den 14. Januar, um 11:30 Uhr ET teilnehmen. Beide Veranstaltungen sind über einen Webcast auf der Unternehmenswebsite zugänglich, mit Aufzeichnungen, die danach verfügbar sind.
- None.
- None.
TARRYTOWN, N.Y., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 third quarter earnings release on Thursday, February 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
ICR Conference
The Company will also participate in a fireside chat at the 27th annual ICR Conference in Orlando, FL on Tuesday, January 14th, at 11:30 a.m. ET. Media and investors can listen to a live audio webcast by visiting the Investor Relations page of the company’s website at www.prestigeconsumerhealthcare.com. A replay of the webcast will be available later that same day.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
FAQ
When will Prestige Consumer Healthcare (PBH) release its Q3 2025 earnings?
What time is PBH's Q3 2025 earnings conference call?
When is Prestige Consumer Healthcare presenting at the ICR Conference?
How can investors access PBH's Q3 2025 earnings call?
